An MRI study of midbrain morphology in patients with schizophrenia: Relationship to psychosis, neuroleptics, and cerebellar neural circuitry

Biological Psychiatry

Volumn 49, Issue 1, 2001, Pages 13-19

  Nopoulos, P C ^a   Ceilley, J W ^a   Gailis, E A ^a   Andreasen, N C ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Brain stem; Magnetic resonance imaging; Mesencephalon; Midbrain; Neuroleptics; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN SIZE; CEREBELLUM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DISORIENTATION; DOPAMINERGIC SYSTEM; HUMAN; MALE; MEDULLA OBLONGATA; MESENCEPHALON; NEGATIVE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN STEM; CEREBELLUM; FEMALE; HUMANS; INTELLIGENCE TESTS; MAGNETIC RESONANCE IMAGING; MALE; MESENCEPHALON; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0035054961     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)01059-3     Document Type: Article

References (48)

1. Cerebellar projections to limbic system
2. Voxel processing techniques for the antemortem study of neuroanatomy and neuropathology using magnetic resonance imaging
3. Image processing for the study of brain structure and function: Problems and programs
4. The Comprehensive Assessment of Symptoms and History (CASH): An instrument for assessing psychopathology and diagnosis
5. Automated atlas-based dissection of the human brain from MR images
6. Magnetic resonance imaging measurement of posterior fossa structures in schizophrenia
7. Post-mortem volume measurements of limbic system and basal ganglia structures in chronic shcizophrenics
8. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics
9. Basal ganglia and limbic system pathology in schizophrenia
10. Midbrain dopamine system electrophysiological functioning: A review and new hypothesis
11. A glutamatergic deficency model of schizophrenia
12. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs
13. Interactions between dopamine and amino acid-induced excitation and inhibition in the striatum
14. Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
15. Change in basal ganglia volume over 2 years in patients with schizophrenia: Typical versus atypical neuroleptics
16. Dose equivalence of the antipsychotic drugs
17. Changed turnover of monoamines in limbic nuclei in response to stimulation and lesion of the anterior vermal cortex of the cerebellum: Studies in cat and rat
18. Stimulation of the paleocerebellar cortex of the cat: Increased rate of synthesis and release of catecholamines at limbic sites
19. Basal ganglia pathology in schizophrenia and Tardive dyskinesia: An MRI quantitative study
20. Childhood-onset schizophrenia: Brain MRI rescan after 2 years of clozapine maintenance treatment
21. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs
22. Tracing neuroepithelial cells of the mesencephalic and metencephalic alar plates during cerebellar ontogeny in quail-chick Chimaeras
23. A new approach to the development of the cerebellum provided by the quail-chick marker system
24. Cerebellar stimulation: Effects on septal region, hippocampus, and amygdala of cats and rats
25. Ascending projections of the cerebellar fastigial nucleus to the hippocampus, amygdala, and other temporal lobe sites: Evoked potential and histological studies in monkeys and cats
26. Practice guidlines for the treatment of patients with schizophrenia
27. Changes in caudate volume with neuroleptic treatment
28. Cerebellar vermis dimensions on computerized tomographic scans of schizophrenic and bipolar patients
29. The concept of dose years: A reliable method for calculating lifetime psychotroptic drug exposure
30. A schizophrenic syndrome associated with a midbrain tegmental lesion
31. An MRI study of cerebellar vermis morphology in patients with schizophrenia: Evidence in support of the "cognitive dysmetria"
32. Sex differences in brain morphology in schizophrenia
33. Cerebellar vermal size in schizophrenia: A male effect
34. Atrophy of the cerebellar vermis: Relevance to the symptoms of schizophrenia
35. A cerebellar-ceruleus pathway
36. Septal afterdischarges and their modification by the cerebellum
37. Cerebellar contributions to the Papez circuit
38. Cerebellar pathways to ventral midbrain and nigra
39. Alterations in forebrain catecholamine metabolism produced by cerebellar lesions in the rat
40. Reduced purkinje cell size in cerebellar vermis of elderly patients with schizophrenia
41. Cooperation of Pax2 and Pax5 in midbrain and cerebellum development
42. Cerebellar pathology in schizophrenia: A controlled postmortem study
43. Cerebellar atrophy in chronic schizophrenia
44. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons
45. Cerebellar and brain stem development: An overview in relation to Joubert Syndrome